Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation
Minyu Wang, Soroor Hediyeh Zadeh, Angela Pizzolla, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004095-e004095
Open Access | Times Cited: 15

Showing 15 citing articles:

Single-cell reference mapping to construct and extend cell-type hierarchies
Lieke Michielsen, Mohammad Lotfollahi, Daniel Strobl, et al.
NAR Genomics and Bioinformatics (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 19
Application of Intravoxel Incoherent Motion in the Prediction of Intra-Tumoral Tertiary Lymphoid Structures in Hepatocellular Carcinoma
Lei Ma, Shuting Liao, Xiaolan Zhang, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 383-398
Open Access
Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)
Kenjiro Namikawa, Takamichi Ito, Shusuke Yoshikawa, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 17967-17980
Open Access | Times Cited: 12
The evolution of BRAF-targeted therapies in melanoma: overcoming hurdles and unleashing novel strategies
Saber İmani, Ghazaal Roozitalab, Mahdieh Emadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
Yue Gao, Xinyue Wang, Longlong Dong, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 6
m6A‐ and m5C‐ modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A‐ modified LINC00893 regulates cutaneous melanoma cell metastasis
Haoze Shi, Cui‐Cui Tian, M. Wu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 1
Morpho-phenotypic characterization of melanoma brain metastases immune microenvironment: a multicentre retrospective study
Filippo Nozzoli, Marco Gessi, Filippo Ugolini, et al.
EJC Skin Cancer (2024) Vol. 2, pp. 100263-100263
Open Access | Times Cited: 1
Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review
Abdulaziz Shebrain, Omer A. Idris, Ali Jawad, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5409-5409
Open Access | Times Cited: 1
Exploring m6A methylation in skin Cancer: Insights into molecular mechanisms and treatment
Mingjun Cai, Xueqing Li, Xueyu Luan, et al.
Cellular Signalling (2024), pp. 111420-111420
Closed Access | Times Cited: 1
Incidence of BRAF Mutations in Cutaneous Melanoma: Histopathological and Molecular Analysis of a Ukrainian Population
Oleksandr Dudin, О. П. Мінцер, Nazarii Kobyliak, et al.
Melanoma Management (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Single-cell reference mapping to construct and extend cell-type hierarchies
Lieke Michielsen, Mohammad Lotfollahi, Daniel Strobl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy
Gusztav Milotay, Martin Little, Robert Watson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma
Francesca Morgese, Valeria Cognigni, Laura Scortichini, et al.
Molecular and Clinical Oncology (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients
Laura Kohtamäki, Suvi‐Katri Leivonen, Siru Mäkelä, et al.
Acta Oncologica (2023) Vol. 62, Iss. 9, pp. 1008-1013
Open Access
Sekvenciranje RNK na ravni posameznih celic: revolucionarna tehnologija, ki nadgrajuje razumevanje kompleksnih bolezni in spodbuja oseben pristop k zdravljenju – primer melanoma kože
Tadeja Kuret, Polonca Ferk
Slovenian Medical Journal (2023), pp. 1-15
Open Access
Page 1

Scroll to top